806 related articles for article (PubMed ID: 18059230)
1. Immunohistochemistry of choriocarcinoma: an aid in differential diagnosis and in elucidating pathogenesis.
Mao TL; Kurman RJ; Huang CC; Lin MC; Shih IeM
Am J Surg Pathol; 2007 Nov; 31(11):1726-32. PubMed ID: 18059230
[TBL] [Abstract][Full Text] [Related]
2. Expression of melanoma cell adhesion molecule in intermediate trophoblast.
Shih IM; Kurman RJ
Lab Invest; 1996 Sep; 75(3):377-88. PubMed ID: 8804361
[TBL] [Abstract][Full Text] [Related]
3. Ki-67 labeling index in the differential diagnosis of exaggerated placental site, placental site trophoblastic tumor, and choriocarcinoma: a double immunohistochemical staining technique using Ki-67 and Mel-CAM antibodies.
Shih IM; Kurman RJ
Hum Pathol; 1998 Jan; 29(1):27-33. PubMed ID: 9445130
[TBL] [Abstract][Full Text] [Related]
4. SALL4 expression in gestational trophoblastic tumors: a useful tool to distinguish choriocarcinoma from placental site trophoblastic tumor and epithelioid trophoblastic tumor.
Stichelbout M; Devisme L; Franquet-Ansart H; Massardier J; Vinatier D; Renaud F; Kerdraon O
Hum Pathol; 2016 Aug; 54():121-6. PubMed ID: 27068524
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical studies of trophoblastic tumors.
Kalhor N; Ramirez PT; Deavers MT; Malpica A; Silva EG
Am J Surg Pathol; 2009 Apr; 33(4):633-8. PubMed ID: 19145204
[TBL] [Abstract][Full Text] [Related]
6. Epithelioid trophoblastic tumor: a neoplasm distinct from choriocarcinoma and placental site trophoblastic tumor simulating carcinoma.
Shih IM; Kurman RJ
Am J Surg Pathol; 1998 Nov; 22(11):1393-403. PubMed ID: 9808132
[TBL] [Abstract][Full Text] [Related]
7. New concepts in trophoblastic growth and differentiation with practical application for the diagnosis of gestational trophoblastic disease.
Shih IM; Kurman RJ
Verh Dtsch Ges Pathol; 1997; 81():266-72. PubMed ID: 9474880
[TBL] [Abstract][Full Text] [Related]
8. Matrix metalloproteinases and their inhibitors in gestational trophoblastic diseases and normal placenta.
Vegh GL; Selcuk Tuncer Z; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 1999 Nov; 75(2):248-53. PubMed ID: 10525381
[TBL] [Abstract][Full Text] [Related]
9. [Immunohistochemical study on trophoblast subpopulations in normal pregnancy and trophoblastic disease].
Sasagawa M
Nihon Sanka Fujinka Gakkai Zasshi; 1985 Oct; 37(10):2010-8. PubMed ID: 3001198
[TBL] [Abstract][Full Text] [Related]
10. P63 expression in hydropic abortion and gestational trophoblastic diseases.
Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
[TBL] [Abstract][Full Text] [Related]
11. HLA Class I protein expression in the human placenta.
Blaschitz A; Hutter H; Dohr G
Early Pregnancy (Cherry Hill); 2001 Jan; 5(1):67-9. PubMed ID: 11753519
[TBL] [Abstract][Full Text] [Related]
12. Galectin-1 and galectin-3 in the trophoblast of the gestational trophoblastic disease.
Bozić M; Petronijević M; Milenković S; Atanacković J; Lazić J; Vićovac Lj
Placenta; 2004 Nov; 25(10):797-802. PubMed ID: 15451194
[TBL] [Abstract][Full Text] [Related]
13. Expression of merosin, a tissue-specific basement membrane protein, in the intermediate trophoblast cells of choriocarcinoma and placenta.
Leivo I; Laurila P; Wahlström T; Engvall E
Lab Invest; 1989 Jun; 60(6):783-90. PubMed ID: 2471877
[TBL] [Abstract][Full Text] [Related]
14. HSD3B1 as a novel trophoblast-associated marker that assists in the differential diagnosis of trophoblastic tumors and tumorlike lesions.
Mao TL; Kurman RJ; Jeng YM; Huang W; Shih IeM
Am J Surg Pathol; 2008 Feb; 32(2):236-42. PubMed ID: 18223326
[TBL] [Abstract][Full Text] [Related]
15. Nuclear beta-catenin and Ki-67 expression in choriocarcinoma and its pre-malignant form.
Wong SC; Chan AT; Chan JK; Lo YM
J Clin Pathol; 2006 Apr; 59(4):387-92. PubMed ID: 16467170
[TBL] [Abstract][Full Text] [Related]
16. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis.
Singer G; Kurman RJ; McMaster MT; Shih IeM
Am J Surg Pathol; 2002 Jul; 26(7):914-20. PubMed ID: 12131159
[TBL] [Abstract][Full Text] [Related]
17. [The early placental trophoblast. II. Tumorous disorders of trophoblast development].
Horn LC; Emmrich P; Bilek K; Bruder E
Zentralbl Gynakol; 1996; 118(11):591-7. PubMed ID: 9082691
[TBL] [Abstract][Full Text] [Related]
18. Expression of epidermal growth factor receptor-related family products in gestational trophoblastic diseases and normal placenta and its relationship with development of postmolar tumor.
Tuncer ZS; Vegh GL; Fulop V; Genest DR; Mok SC; Berkowitz RS
Gynecol Oncol; 2000 Jun; 77(3):389-93. PubMed ID: 10831347
[TBL] [Abstract][Full Text] [Related]
19. Placental site nodule and characterization of distinctive types of intermediate trophoblast.
Shih IM; Seidman JD; Kurman RJ
Hum Pathol; 1999 Jun; 30(6):687-94. PubMed ID: 10374778
[TBL] [Abstract][Full Text] [Related]
20. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
